Because mitochondrial oxidative stress and impairment are important mediators of neuronal damage in neurodegenerative diseases and in brain ischemia/reperfusion, in the present study, we evaluated the antioxidant and mitoprotective effect of a new promising neuroprotective molecule, JM-20, in mitochondria and synaptosomes isolated from rat brains. JM-20 inhibited succinate-mediated H 2 O 2 generation in both mitochondria and synaptosomes incubated in depolarized (high K + ) medium at extremely low micromolar concentration and with identical IC 50 values of 0.91 M. JM-20 also repressed glucoseinduced H 2 O 2 generation stimulated by rotenone or by antimycin A in synaptosomes incubated in high sodium-polarized medium at extremely low IC 50 values of 0.395 M and 2.452 M, respectively. JM-20 was unable to react directly with H 2 O 2 or with superoxide anion radicals but displayed a cathodic reduction peak at −0.71 V, which is close to that of oxygen (−0.8 V), indicating high electron affinity. JM-20 also inhibited uncoupled respiration in mitochondria or synaptosomes and was a more effective inhibitor in the presence of the respiratory substrates glutamate/malate than in the presence of succinate. JM-20 also prevented Ca 2+ -induced mitochondrial permeability transition pore opening, membrane potential dissipation and cytochrome c release, which are key pathogenic events during stroke. This molecule also prevented Ca 2+ influx into synaptosomes and mitochondria; the former effect was a consequence of the latter because JM-20 inhibition followed the patterns of carbonyl cyanide p-trifluoromethoxyphenyl hydrazone (FCCP), which is a classic mitochondrial uncoupler. Because the mitochondrion is considered an important source and target of neuronal cell death signaling after an ischemic insult, the antioxidant and protective effects of JM-20 against the deleterious effects of Ca 2+ observed at the mitochondrial level in this study may endow this molecule with the ability to succeed in mitochondrion-targeted strategies to combat ischemic brain damage.
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Introduction
Oxidative stress is implicated in the pathogenesis of progressive neuron deterioration associated with excitotoxicity observed in chronic and acute brain diseases or in aging (Chen et al., 2011;  http://dx.doi.org/10.1016/j.brainresbull.2014.10.001 0361-9230/© 2014 Elsevier Inc. All rights reserved. Manzanero et al., 2013; Perluigi et al., 2013; Wang and Qin, 2010) . Because mitochondria are the major sites for reactive oxygen species (ROS) generation in neurons (Lin and Beal, 2006) , these organelles are a focus for determining new neuroprotective agents; evidence has accumulated that suggest a crucial role for mitochondrial defects in the pathogenesis of these conditions by initiating and promoting oxidative stress.
Recently, we obtained a new family of 1,5-benzodiazepines that structurally differ from the currently available 1,5-benzodiazepines due to the presence of a 1,4-dihydropyridine moiety fused to the benzodiazepine ring. JM-20 (3-ethoxycarbonyl-2-methyl-4-(2-nitrophenyl)-4,11-dihydro-1H-pyrido [2,3-b] [1,5] benzodiazepine), which is a member of this compound family (Fig. 1) , has an anxiolytic profile similar to that of diazepam (Figueredo et al., 2013) . At a low micromolar concentration, we observed JM-20 prevents the Ca 2+ -induced mitochondrial permeability transition, membrane potential dissipation, and pro-apoptotic protein cytochrome c release, and inhibits the hydrolytic activity of F 1 F 0 -ATP synthase in rat liver mitochondria (Nuñez-Figueredo et al., 2014a) . We hypothesized that these mitoprotective effects may be involved in the neuroprotection elicited by JM-20 in several in vitro models relevant to cerebral ischemia (Nuñez-Figueredo et al., 2014a) . We also reported an important protective effect of JM-20 against hydrogen peroxide (H 2 O 2 )-or glutamate-induced PC-12 cell death or KCN-mediated chemical hypoxia (Nuñez-Figueredo et al., 2014a) . Because oxidative stress and mitochondrial impairment are key mediators of the ischemic process, particularly after reperfusion (Chan, 2005; Niizuma et al., 2009) , we examined the antioxidant effects of JM-20 in rat brain mitochondria and in a synaptosomal preparation. To support the mitoprotective hypothesis of JM-20 neuroprotection, we also assessed its mitoprotective effect on Ca 2+ -induced mitochondrial dysfunction using isolated mitochondria from rat brains. We observed that JM-20 acts equally as a potent antioxidant in mitochondria or in synaptosomes most likely due to its high electron-affinity at the organelle level. Our results also indicate that the mitoprotection against Ca 2+ -mediated mitochondrial impairment may involve Ca 2+ uptake inhibition at the mitochondrial level, which could play a role in the mechanism of action of JM-20 as a neuroprotectant.
Materials and methods

Compounds and reagents
All chemicals and enzymes used were of the highest grade available and were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise specified. Stock solutions of JM-20 were prepared daily in dimethyl sulfoxide (DMSO) and added to the reaction media at 1/1000 (v/v) dilution. Control experiments contained DMSO at 1/1000 dilution. JM-20 was synthesized, purified and characterized as previously reported (Figueredo et al., 2013) .
Isolation of synaptosomal preparation and mitochondria
The forebrains from male Wistar rats (3-4 months old) were rapidly removed and homogenized in isolation buffer containing 0.32 M sucrose, 1 mM ethylenediaminetetraacetic acid (EDTA) (K + salt), and 10 mM Tris-HCl (pH 7.4). The homogenate was centrifuged at 1330 × g for 3 min. The supernatant was carefully retained and centrifuged at 16,000 rpm (21,200 × g) for 10 min. The pellet was resuspended, carefully layered on the top of a discontinuous Percoll gradient and centrifuged for 5 min at 30,700 × g (Sims, 1990; Sims and Anderson, 2008) . The synaptosomal and mitochondrial fractions were incubated in depolarized buffer (high K + : 100 mM KCI, 75 mM mannitol, 25 mM sucrose, 5 mM phosphate, 0.05 mM EDTA, and 10 mM Tris-HCl, pH 7.4) and synaptosomal was also incubated in polarized buffer (high Na + : 140 mM NaCl, 20 mM HEPES, 10 mM d-glucose, 1.2 mM Na 2 HPO 4 , 1 mM MgCl 2 , 5 mM NaHCO 3 , and 5 mM KCl, pH 7.4). The mitochondrial respiratory control ratio (state 3/state 4 respiratory rate ratio) was over 5, measured using 5 mM glutamate and 5 mM malate as NADH-linked substrates. Animal care followed the official governmental guidelines in compliance with the Federation of Brazilian Societies for Experimental Biology and was approved by the Ethics Committee of the Federal University of Rio Grande do Sul, Brazil.
ROS production
The mitochondrial release of H 2 O 2 was assessed by the Amplex Red oxidation method. The synaptosomal or mitochondrial fractions (0.1 mg protein/ml) were incubated in the polarized or depolarized buffer supplemented with 10 M Amplex Red and 2 units/ml of horseradish peroxidase (HRP). The fluorescence was monitored at excitation (563 nm) and emission wavelengths (587 nm) using a Spectra Max M5 microplate reader (Molecular Devices, Orleans Drive Sunnyvale, CA, USA). Catalase (EC 1.11.1.6) at 10 U/ml was used as a positive control. Each experiment was repeated 5 times with different synaptosomal or mitochondrial preparations.
Superoxide anion radical scavenging assay
Superoxide anion radical (O 2
•− ) generated by the xanthine/xanthine oxidase (EC 1.17.3.2) system was determined spectrophotometrically by monitoring the reduction products of nitroblue tetrazolium (NBT) (Nagai et al., 2001 ). The reaction mixture consisted of 3 mM xanthine, 3 mM EDTA, 15 mM NBT, and JM-20 (0.5, 1, 3, 5, 25 M final concentrations) in 50 mM phosphate buffer (pH 7.4). After incubation at 25 • C for 2 min, the reaction was initiated by adding 0.05 U/ml xanthine oxidase and carried out at 25 • C for 10 min. The absorbance was measured at 560 nm. The reaction mixture without xanthine oxidase was used as a blank. Superoxide dismutase enzyme (SOD, EC 1.15.1.1) at 2 U/ml was used as positive control. The superoxide anion radical level was expressed as the percentage of NBT reduction versus control (set at 100%), which did not contain JM-20 or SOD.
The effect of JM-20 on enzyme activity was studied by estimating the uric acid formation from xanthine after 10 min incubation at 25 • C, while absorbance was measured at 295 nm. The absorbance was monitored using a Spectra Max M5 microplate reader (Molecular Devices, Orleans Drive Sunnyvale, CA, USA).
Oxygen (O 2 ) measurement
The O 2 consumption rates were measured polarographically using high-resolution respirometry (Oroboros Oxygraph-O2 K, Oroboros Instruments, Innsbruck, Austria). Synaptosomal or mitochondrial fractions (0.1 mg/ml) were incubated with polarized buffer supplemented with 5 mM succinate plus 2.5 M rotenone, or 5 mM glutamate plus 5 mM malate in the absence or presence of JM-20 for 1 min at 37 • C under continuous stirring. The respiratory protonophoric uncoupler carbonyl cyanide ptrifluoromethoxyphenyl hydrazone (FCCP, 1 M) was added, and the oxygen consumption rates were registered for 10 min.
ATP assay in mitochondria
ATP was determined by the firefly luciferin-luciferase assay system (Lemasters and Hackenbrock, 1976) . Mitochondria (0.1 mg/ml) were incubated in depolarized buffer energized with 5 mM glutamate plus 5 mM malate, and supplemented with 1 mM ADP. After 10 min incubation in the absence or presence of JM-20 (5 M) or oligomycin A (1 M), the mitochondrial suspension (0.1 mg protein/ml) was centrifuged at 9000 × g for 5 min at 4 • C and the pellet treated with 1 ml of ice-cold 1 M HClO 4 . After centrifugation at 12,000 × g for 5 min at 4 • C, 100 l aliquots of the supernatants were neutralized with 70 l of 2 M KOH, suspended in 100 mM Tris-HCl, pH 7.8 (final volume, 1 ml), and centrifuged at 15,000 × g for 15 min. Bioluminescence was measured in the supernatant with a Sigma/Aldrich assay kit, according to the manufacturer's instructions, using an AutoLumat LB953 Luminescence photometer (Perkin-Elmer Life Sciences, Wilbad, Germany).
Electrochemical assays
Electrochemical assays were performed using a BAS CV-27 potentiostat (Bioanalytical System, Inc., West Lafayette, IN, USA) by employing conventional electrochemical cells with 3 electrodes; the data were recorded using an Omnigraphic 100 recorder (Texas Instruments, Houston, TX, USA). A 0.0314 cm 2 geometric area glassy carbon electrode, which was polished with 1 m alumina-water suspension and rinsed thoroughly with water and acetone, was used as the working electrode. A platinum wire was used as the counter electrode, and all potentials are referenced to a sodium-saturated silver/silver chloride electrode [Ag/AgCl/KCl (sat) ] without regard for the liquid junction potential. The cyclic voltammetric studies were performed at a 100 mV/s sweep rate in 5 ml of 0.1 M phosphate buffer solution (pH 7.0), where aliquots of a 33 M solution of JM-20 in DMSO were added. Because the cyclic voltammograms were recorded at a window potential including negative ranges, oxygen-free solution was obtained by bubbling argon through the solution. When the potential was scanned, the inert gas was kept in the solution to ensure that any oxidation reaction was not initiated by oxygen.
Determination of mitochondrial swelling, membrane potential ( m ) dissipation and cytochrome c release
Mitochondrial swelling was estimated from the decrease in the apparent absorbance at 540 nm. The mitochondrial membrane potential ( m ) was estimated spectrofluorimetrically using 10 M Safranine O as a probe (Zanotti and Azzone, 1980) at the 495/586 nm excitation/emission wavelength pair. For cytochrome c estimation, mitochondrial suspensions were centrifuged at 12,000 × g in an Eppendorf centrifuge for 10 min at 4 • C, and the differential absorption spectra (reduced with dithionite/oxidized) of the supernatants were recorded in a 96-well plate (l = 1 cm). The cytochrome c absorption extinction coefficient (A 550 -A 540 nm) was assumed to be 19.1 (mM cm) −1 (Kruglov et al., 2008; Nuñez-Figueredo et al., 2014b) . All of the experiments were performed with 1 mg/ml mitochondrial protein, incubated for 10 min in depolarized buffer (without EDTA) supplemented with 50 M Ca 2+ and 5 mM succinate plus 2.5 M rotenone, in the absence (Control) or presence of JM-20 or with a mixture of ADP (250 M) plus oligomycin A (1 M), which is a classical combination that inhibits the mitochondrial permeability transition in rat brain mitochondria (Saito and Castilho, 2010) . The absorbance or fluorescence was monitored using a Spectra Max M5 microplate reader (Molecular Devices, Orleans Drive Sunnyvale, CA, USA).
Ca 2+ influx
Ca 2+ influx was monitored spectrofluorimetrically using 150 nM Calcium Green-5N (Molecular Probes, OR, USA) as a probe at the 506/531 nm excitation/emission wavelength pair (Rajdev and Reynolds, 1993) . The mitochondrial or synaptosomal fractions (0.1 mg protein/ml) were incubated for 1 min with JM-20 (0.5, 1, 3, 5 M), FCCP (1 M), Nimodipine (5 M), or their combinations before Ca 2+ addition (50 M final concentration) in depolarized medium (without EDTA) energized with 5 mM succinate plus 2.5 M rotenone. The fluorescence differences from t = 0 and t = 600 s after Ca 2+ addition ( Fluorescence) were recorded using a Spectra Max M5 microplate reader (Molecular Devices, Orleans Drive Sunnyvale, CA, USA).
Statistical analysis
GraphPad Prism 5.0 software (GraphPad Software Inc., USA) was used for statistical analyses. The data are expressed as the mean ± SEM. Comparisons among different groups were performed using a one-way analysis of variance (ANOVA), followed by the Newman-Keuls multiple comparison post hoc test. Differences were considered statistically significant at p < 0.05. The IC 50 values were estimated using a non-linear regression algorithm.
Results
3.1.
Effects of JM-20 on succinate-mediated H 2 O 2 generation in rat brain synaptosomal and mitochondrial fractions under high K + depolarizing conditions Fig. 2 shows that mitochondria (A) and synaptosomes (B) were responsive to succinate, as evidenced by the increase in the H 2 O 2 generation rate when comparing the control (succinate) and basal rates. Additionally, JM-20 decreased H 2 O 2 generation in both fractions in a concentration-dependent manner. An excess of catalase (10 U/ml) over HRP (2 U/ml) used as a positive control, almost completely reduced H 2 O 2 generation, as expected. Neither succinate (5 mM) nor JM-20 (5 M) interfered with Amplex Red florescence, after 10 min incubation in the absence of HRP (result not shown). Similar IC 50 values were obtained for both preparations (0.91 M), suggesting that JM-20 may act as an antioxidant at the mitochondrial level.
To improve the H 2 O 2 generation capacity of the synaptosomal preparation, we used a buffer with high K + to depolarize the membranes and to increase the H 2 O 2 production compared with the polarized buffer (Sims and Blass, 1986) . This experimental strategy alters the membrane permeability during the incubation and permits the detection of classical mitochondrial responses stimulated by succinate (Sims and Blass, 1986) . release from synaptosomes into the medium was measured after the addition of glucose, which is taken up by nerve terminals and metabolized and which serves as an energy source (Tretter et al., 2005) . Fig. 3 shows that glucose slightly increased H 2 O 2 production in synaptosomes; this effect was strongly potentiated by the mitochondrial complex I and III inhibitors rotenone (A) and antimycin A (B). Under both of these conditions, JM-20 also inhibited H 2 O 2 generation in a concentration-dependent manner and was almost seven times more potent as an antioxidant against rotenone (IC 50 = 0.40 M) compared with antimycin A (IC 50 = 2.45 M). Glucose (10 mM), rotenone (2.5 M), or antimycin A (1 M) did not affect Amplex Red fluorescence after 10 min incubation in the absence of HRP (result not shown). As in Fig. 2 , catalase (10 U/ml) abolished H 2 O 2 generation. formation; and/or (iv) its ability to prevent superoxide formation by competing with oxygen for one-electron reduction in the mitochondrial electron transport chain. We performed sets of experiments (in mitochondrial/synaptosomal fraction-free systems) aiming to understand the antioxidant mechanism of JM-20. Fig. 4 shows that JM-20 was unable to direct react with H 2 O 2 (B), did not interfere with HRP catalytic function (A), and did not react with xanthine oxidase-generated superoxide anion radicals (C). This molecule did not interfere with the xanthine oxidase catalytic activity (result not shown). ATP generation, the observed ability of JM-20 to inhibit the respiration of FCCP-treated mitochondria indicated that this molecule did not inhibit the adenine nucleotide transporter. Since JM-20 was unable to disrupt mitochondrial membrane organization (result not shown), these results suggest that JM-20 has the ability to scavenge electrons from the mitochondrial energized membrane, diminishing the possibility of electron withdrawal and superoxide anion radical formation. 
Effects of JM-20 on uncoupled respiration in rat brain mitochondrial and synaptosomal fractions
Effects of JM-20 on mitochondrial ATP levels
To clarify whether the inhibitory effect of JM-20 on uncoupled respiration may interfere with the ATP synthesis in mitochondria, it was evaluated its effects on ATP levels. After 10-min incubation JM-20 did not affect the ATP levels of isolated rat-brain mitochondria (Fig. 6) . It denotes none energetic impairment by JM-20 at comparable experimental condition to that eliciting antioxidative and Calcium protection.
Electrochemical analysis of JM-20
We also analyzed the electrochemical behavior of JM-20. A reduction peak at ca. −0.71 V versus Ag/AgCl/NaCl sat in the first cathodic scan (Fig. 7) was observed for JM-20; we ascribed this peak to a nitro reduction mechanism (Núñez-Vergara et al., 1997). The JM-20 cathodic peak potential value is close to that of oxygen (-0.8 V), suggesting similar electron affinities and making JM-20 an oxygen competitor for electrons under low oxygen concentration. These findings may explain the antioxidant effect of JM-20 and its ability to inhibit uncoupled respiration.
3.7. Effects of JM-20 on Ca 2+ -mediated rat brain mitochondrial swelling, membrane potential dissipation and cytochrome c release A key pathogenic event during stroke is the opening of the mitochondrial permeability transition pores (mPTP) in the inner mitochondrial membrane (Hirsch et al., 1998) . In the next set of experiments, we assessed the effects of JM-20 on Ca 2+ -and Pi-induced mPTP opening, as estimated by the swelling of succinate-energized rat brain mitochondria. This classic swelling technique monitors the net influx of the osmotic support associated with a non-specific increase in membrane permeability. Fig. 8A shows that 50 M Ca 2+ plus 5 mM Pi induced mitochondrial swelling, as revealed by the large decrease in the turbidity of the mitochondrial suspension at 540 nm (trace a: control without JM-20). This swelling was associated with a faster mitochondrial membrane potential dissipation (Fig. 8B, Ca 2+ ). JM-20 (5 M) almost completely inhibited both swelling and mitochondrial membrane potential dissipation (trace d, Fig. 8A and B, respectively) in a similar manner to the protection elicited by the classic mPTP inhibitor mixture ADP plus oligomycin A (trace e, Fig. 8A and B, respectively).
Cytochrome c release from the mitochondria plays an important role in cell death (Li et al., 1997) . Because we previously demonstrated that JM-20 prevented neuronal cell death in different paradigms associated with the ischemic process (Nuñez-Figueredo et al., 2014a) , next, we assessed the potential involvement of cytochrome c release inhibition in JM-20 effects in this study. Ca 2+ /Pi overload induced a substantial release of cytochrome c from rat brain mitochondria (Fig. 8C) 3.8. Effects of JM-20 on Ca 2+ influx into rat brain mitochondrial or synaptosomal fractions JM-20 inhibited Ca 2+ influx in succinate-energized rat brain mitochondrial and synaptosomal fractions in a concentrationdependent manner (Fig. 9A) . The co-incubation of FCCP with increasing concentrations of JM-20 did not increase the inhibitory potency of either compound alone (Fig. 9B) , suggesting that the Ca 2+ uptake inhibition elicited by JM-20 may be localized at the mitochondrial level. In fact, the well-known L-type Ca 2+ channel blocker nimodipine produced approximately 50% Ca 2+ uptake inhibition; 
Discussion
Numerous pieces of evidence show that ROS are involved in brain lesions, including those lesions due to cerebral ischemiareperfusion (Allen and Bayraktutan, 2009; Chen et al., 2011; Manzanero et al., 2013) . Mitochondria are the primary intracellular source of ROS because these organelles generate many oxidative-reduction reactions and use massive amounts of oxygen (Adam-Vizi, 2005; Lin and Beal, 2006 ). When anoxia is followed promptly by reperfusion, the resulting increase in oxygen supply leads to ROS overproduction (Han et al., 2001; Liu et al., 2002) . In ischemic tissues, several studies have established a direct role for ROS in oxidative damage to lipids, proteins, and nucleic acids (Allen and Bayraktutan, 2009; Chen et al., 2011; Manzanero et al., 2013) . Thus, mitochondria are both the initiators and the first targets of oxidative stress. Mitochondrial damage can lead to cell death, given the role of mitochondria in energy metabolism and in calcium homeostasis, as well as the ability of mitochondria to release pro-apoptotic factors, such as cytochrome c and apoptosisinducing factor (AIF) (Fiskum, 2000; Fiskum et al., 1999; Lau and Tymianski, 2010; Niizuma et al., 2009) . Thus, antioxidants targeting mitochondrial oxidative stress and mitoprotectors are the primary focus of neuroprotectant research. In this work, we observed that JM-20, which is a novel benzodiazepine-dihydropyridine hybrid molecule, is a strong antioxidant that acts at both synaptosomal and mitochondrial levels. Its antioxidant action was not related to its ability to scavenge superoxide anion radicals or hydrogen peroxide but to its strong electron affinity given by its low redox potential similar to that of oxygen. This electrochemical characteristic endows JM-20 with the ability to scavenge electrons from the mitochondrial electron transport chain (METC) or even to compete with oxygen for the electrons released from mitochondria, thus preventing ROS formation. We believe that the presence of a nitro group in the JM-20 dihydropyridine portion may be responsible for this antioxidant action. In this regard, the antioxidant effects of several dihydropyridine derivatives on Fe 3+ /ascorbate-stimulated lipid peroxidation in rat brain slices has been reported (Díaz-Araya et al., 1998) . Additionally, a potent reduction of alkylperoxyl and ABTS radicals by 1,4-dihydropyridines involving an electron transfer process has been documented (Yáñez et al., 2004) . In fact, several 1,4-dihydropyridines inhibit oxygen consumption by T. cruzi Tulahueín strain epimastigotes. The drugs with higher electron-affinity produced greater inhibition than did those drugs with lower electron-affinity (Núñez-Vergara et al., 1997) . These nitro-containing molecules could be reduced at the mitochondrial electron transport chain from parasites, thus inhibiting mitochondrial respiration. In the present study, we observed that JM-20 inhibited uncoupled respiration in isolated rat brain mitochondria, producing two times greater inhibition when glutamate/malate (complex I-linked substrates) were used as the energy source. This finding suggests that JM-20 reduction by the METC may involve the entire chain, particularly the upper levels of transporters where the electrochemical redox values are lower.
It is important to note that the IC 50 value for the uncoupled respiration inhibition by JM-20 (12.31 M) is more than 10 times higher than those for the antioxidant effects elicited by JM-20 on mitochondria or synaptosomes under depolarizing or polarizing conditions (Figs. 2 and 3) . Furthermore, high thresholds of inhibition of activity of Complexes I, III and IV (more than 70%), are needed before major changes in ATP production occur in isolated brain mitochondria (Kilbride et al., 2011; Rossignol et al., 1999; Mazat et al., 2001) . These circumstances make improbable that JM-20 interferes with mitochondrial respiration and ATP synthesis at antioxidative or mitoprotective concentrations as evidenced by the lack of effect of this molecule on the ATP output in tightly coupled mitochondria (Fig. 6) .
Under polarized conditions (high Na + medium) where synaptosome membrane integrity is preserved, JM-20 also elicited strong antioxidant actions and was more potent when H 2 O 2 production was stimulated by the mitochondrial complex I inhibitor rotenone. Because we observed that JM-20 did not react with H 2 O 2 , this result suggests that this molecule crosses synaptosomal membranes and targets mitochondria, thus preventing ROS formation. Because reactive oxygen species generated from mitochondria have been implicated in acute brain injuries, such as stroke (Manzanero et al., 2013; Niizuma et al., 2009) , and because inhibiting ROS production at the source rather than scavenging the already produced oxidant agents, is already displaying positive outcomes (Hill et al., 2012; Manzanero et al., 2013) , JM-20 could be a potential candidate for antioxidant therapy after ischemic brain damage.
ROS generation reduction at the mitochondrial level is not the only strategy to protect neurons after an ischemic event. Several aspects of mitochondrial function, which are not necessarily linked with ROS generation, could also be modulated to prevent mitochondrial impairment and mitochondrial-mediated apoptosis signaling initiation. In this regard, the excessive mitochondrial Ca 2+ loading following an ischemic insult may result in mitochondrial permeability transition pore (mPTP) opening (Sullivan et al., 2005) . In turn, this mPTP opening will result in a massive leak of protons and complete and immediate dissipation of the mitochondrial membrane potential, indicating a commitment to death. Cytochrome c release from the inter-membrane space of the mitochondria to the cytosol is one of the critical events that occur during apoptotic neuronal cell death (Fiskum, 2000; Lau and Tymianski, 2010) . Because diazepam and nimodipine, both of which exhibit structural similarities to JM-20, have been reported to protect neuronal cells in different experimental models of brain ischemia via mitochondrial mechanisms (Sarnowska et al., 2009; Taya et al., 2000) , in the present study, we also addressed the idea that brain mitochondria are potential pharmacological targets for the neuroprotective action of JM-20. We also demonstrated the protective effect of JM-20 against Ca 2+ -induced mPTP opening, the dissipation of the membrane potential and the inhibition of Ca 2+ -induced cytochrome c release from rat brain mitochondria. JM-20 also significantly prevented mitochondrial Ca 2+ influx, which may have been responsible for the Ca 2+ -induced mitochondrial swelling. In this regard, abnormal Ca 2+ accumulation by neuronal mitochondria in response to excitotoxic levels of excitatory neurotransmitters, such as glutamate, is an important mediator of mitochondrial dysfunction and of delayed cell death (Drago et al., 2011; Fiskum, 2000) . Thus, JM-20-mediated protection against Ca 2+ -induced mitochondrial impairment and its neuroprotective effects may include its ability to prevent mitochondrial Ca 2+ influx. Notably, the inhibition of Ca 2+ influx into synaptosomes by JM-20 followed the inhibitory patterns of the mitochondrial uncoupler FCCP and was different from that of nimodipine, which is a wellknown L-type Ca 2+ channel blocker. Indeed, the combination of FCCP with increasing concentrations of JM-20 did not induce further Ca 2+ uptake inhibition greater than that induced by JM-20 or by FCCP alone in synaptosomes. The combination of JM-20 or FCCP plus nimodipine prompted a more than 30% increase in Ca 2+ influx inhibition. These results suggest that the synaptosomal inhibition of Ca 2+ uptake elicited by JM-20 is most likely related to its ability to block mitochondrial Ca 2+ entry, similar to FCCP. This inhibition of Ca 2+ uptake at the mitochondrial level may increase cytoplasmic Ca 2+ concentrations in synaptosomes, thus leading to a diffusional impairment of further synaptosomal Ca 2+ influx. Therefore, although the chemical structure of JM-20 includes a dihydropyridine moiety, JM-20 seems to be unable to block voltagedependent Ca 2+ channels at synaptosomal membranes under our experimental conditions. Recently, we observed that the strong neuroprotective in vivo effect of JM-20 against an experimental model of ischemic brain damage was related to lower Ca 2+ accumulation into the brain mitochondria (Nuñez-Figueredo et al., 2014b) . In this previous work, we raised the hypotheses that JM-20 could be inhibiting the Ca 2+ uptake at neuronal membranes, at mitochondrial membranes, or at both levels. The present results suggest that this molecule is most likely acting at the mitochondrial level.
In conclusion, this work reveals two primary aspects of the neuroprotective mechanism of JM-20: (i) its strong antioxidant action and (ii) its protective effects against Ca 2+ -induced impairment, which are both elicited at the mitochondrial level. The combination of two privilege structures into one molecule, a dihydropyridine moiety with a nitroaromatic group and a benzodiazepine ring supporting a net positive charge and a high level of lipophilicity, may allow the new chemical entity to cross the blood-brain barrier and cell membranes, selectively targeting mitochondria. Recently, we observed important anxiolytic and sedative effects of JM-20 on different in vivo experimental models with a lack of toxic effects, indicating its ability to reach the central nervous system at low doses (Figueredo et al., 2013) . Because mitochondria are considered one of the important sources and targets of neuronal cell death signaling after an ischemic insult, JM-20 has the potential to succeed in mitochondrion-targeted strategies to combat ischemic brain damage.
